News Cellular Intelligence scoops up Novo's Parkinson's therapy Novo Nordisk has sold the rights to one of the flagship candidates in its now-defunct cell therapy unit to AI start-up Cellular Intelligence.
News AI-powered study finds multiple Parkinson’s types Researchers have used a machine learning algorithm to try to work out why Parkinson's disease patients can respond so differently to treatment.
News New NIHR-funded TRC for Parkinson’s disease The launch of a new national research collaboration focused on Parkinson’s disease has been announced.
R&D Parkinson’s Awareness Month may end, but the research impera... As Parkinson’s Awareness Month comes to a close, the urgency to challenge the status quo has never been greater.
R&D Parkinson’s disease: Transitioning from symptom control to d... The Parkinson's disease field is increasingly moving toward biologically defined disease frameworks using molecular biomarkers.
News Parkinson's charity partners Biognosys on biomarker project A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.